| Application no. and date | 17735440.4 (espacenet) (Federated) (European Patent Register), 20170627 | | Patent/reg. no. and date | DK/EP 3475303, 20210414 | | Publication date | 20190501 | | Priority no. and date | EP 16176322, 20160627 | | EP pub. no. and date |
EP 3475303 20190501 | | Effective date | | | Applicant/owner | Incyte Corporation, 1801 Augustine Cut-Off
Wilmington
Delaware 19803
, US | | Applicant ref. no. | P76222DK01 | | Inventor | GARIDEL, Patrick, Boehringer Ingelheim GmbH
Binger Str. 173
55216 Ingelheim am Rhein, DE,
LANGER, Andreas, Boehringer Ingelheim GmbH
Binger Str. 173
55216 Ingelheim am Rhein, DE,
WEINFURTNER, Daniel, MorphoSys AG
Semmelweisstr. 7
82152 Planegg, DE,
BROCKS, Bodo, MorphoSys AG
Semmelweisstr. 7
82152 Planegg, DE,
HESSLING, Martin, Tunnelweg 2
88400 Biberach, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | ANTI-CD19-ANTISTOFFORMULERINGER | | Int. application no. | EP2017065819 | | Int. publication no. | WO2018002031 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
